Clinical observation for the effect of Ke-Gan-Li-Yan oral liquid on the relief of laryngeal symptoms of novel coronavirus pneumonia (COVID-19) convalescence and suspected patients and other susceptible people

The Fifth Affiliated Hospital of Sun Yat-Sen University0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. At the time of signing the informed consent, male or female aged 18 to 65 years old;
•2. Covid-19 convalescent patients, suspected patients, fever and other susceptible groups with respiratory symptoms of laryngeal discomfort;
•3. The TCM syndrome differentiation of pharyngeal discomfort in the above population is as follows: dampness-heat accumulation lung syndrome/wind-heat syndrome/wind-heat invasion lung syndrome/phlegm-heat obstructing lung syndrome/lung-heat blazing syndrome/lung-stomach solid heat syndrome and other TCM syndromes;
•4. Subject is informed and voluntarily signs an informed consent and agrees to participate in all visits as required by the study protocol.

•1. The researcher decides that it is not in the best interests of the subject to participate in this study, or there is any situation that the protocol cannot be safely followed;
•2. Known allergic reaction or allergic constitution to gramanliyan oral liquid or its components;
•3. Have participated in or are participating in other clinical researchers within the past 1 month;
•4. Positive pregnancy test during pregnancy or breastfeeding or before medication;
•5. Other circumstances considered inappropriate for the study.

发起方

The Fifth Affiliated Hospital of Sun Yat-Sen University